VO659

· Vico Therapeutics B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VO659, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD [Phase 1, Phase 2]